NDC 48951-2014

Bambusa Pulsatilla

Bambusa Pulsatilla

Bambusa Pulsatilla is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Uriel Pharmacy Inc.. The primary component is Viscum Album Fruiting Top; Equisetum Arvense Top; Formica Rufa; Pulsatilla Vulgaris; Bambusa Vulgaris Whole; Stachys Officinalis; Bos Taurus Intervertebral Disc; Rosmarinus Officinalis Flowering Top; Tin; Ferrosoferric Phosphate; Silicon Dioxide.

Product ID48951-2014_6c7cf17f-e569-574a-e053-2991aa0a0818
NDC48951-2014
Product TypeHuman Otc Drug
Proprietary NameBambusa Pulsatilla
Generic NameBambusa Pulsatilla
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2009-09-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameUriel Pharmacy Inc.
Substance NameVISCUM ALBUM FRUITING TOP; EQUISETUM ARVENSE TOP; FORMICA RUFA; PULSATILLA VULGARIS; BAMBUSA VULGARIS WHOLE; STACHYS OFFICINALIS; BOS TAURUS INTERVERTEBRAL DISC; ROSMARINUS OFFICINALIS FLOWERING TOP; TIN; FERROSOFERRIC PHOSPHATE; SILICON DIOXIDE
Active Ingredient Strength3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 48951-2014-1

10 AMPULE in 1 BOX (48951-2014-1) > 1 mL in 1 AMPULE
Marketing Start Date2009-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 48951-2014-1 [48951201401]

Bambusa Pulsatilla LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-09-01

Drug Details

Active Ingredients

IngredientStrength
VISCUM ALBUM FRUITING TOP3 [hp_X]/mL

OpenFDA Data

SPL SET ID:0776c3be-088d-422c-9c12-08fcaae823e1
Manufacturer
UNII

NDC Crossover Matching brand name "Bambusa Pulsatilla" or generic name "Bambusa Pulsatilla"

NDCBrand NameGeneric Name
48951-2014Bambusa PulsatillaBambusa Pulsatilla
48951-2015Bambusa PulsatillaBambusa Pulsatilla

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.